RecruitingNCT06270537

Post-market Clinical Trial of the Dominus® Stent-Graft

Multicenter Study Collecting Post-market Clinical Data on the Dominus® Stent-Graft for Treating Thoracic Aortic Diseases

Sponsor

Braile Biomedica Ind. Com. e Repr. Ltda.

Enrollment

100 participants

Start Date

Oct 24, 2023

Study Type

OBSERVATIONAL

Conditions

thoracic aortic dissection

Summary

Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Stent-Graft Dominus® Endoprosthesis for people with thoracic aortic dissection. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEStent-Graft Dominus® Endoprosthesis

Placement of the Dominus® Stent-Graft for endovascular repair of diseases of the Thoracic Aorta

Locations(3)

Hospital Evangélico de Vila Velha

Vila Velha, Espírito Santo, Brazil

Hospital Nossa Senhora da Conceição

Porto Alegre, Rio Grande do Sul, Brazil

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

Ribeirão Preto, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06270537

Related Trials

Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients

NCT063362131 location

ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"

NCT053097071 location